THOR is a targetable epigenetic biomarker with clinical implications in breast cancer
Article in Clinical Epigenetics (December 2022)
The most recent citing publications are shown below. View all 33 publications that cite this research output on Dimensions.
Article in Clinical Epigenetics (December 2022)
Article in European Journal of Cancer (June 2022)
Article in npj Breast Cancer (June 2022)